Postdoctoral Fellow in Quantitative Biology and Longevity Research

Organization
Translational Genomics Research Institute (TGen)
Job Location
445 N 5th
Phoenix, AZ 85004
Job Description

Dr. Nicholas Schork, Director of Quantitative Medicine at TGen, seeks a creative, independent, and highly motivated researcher interested in developing and applying novel and comprehensive quantitative methods for understanding and characterizing the genetic and molecular determinants of human longevity and longevity enhancement. Dr. Schork is one of the two principal investigators (PIs) for the NIA-funded longevity consortium, whose goal is to characterize the genetic basis of human longevity, and a co-PI on another NIA-funded consortium grant to identify genetic targets for longevity-enhancing interventions. The methods, analyses, and tools to be developed will leverage these connections, but go beyond them, in developing bioinformatic and biostatical analysis methods to identify genetic longevity-enhancing intervention targets and designing studies to test their effects.                   

Brief Professional Activities Description                             

The post-doctoral fellow will have the opportunity to develop and evaluate quantitative methods for interrogating genetically-mediated factors that impact human longevity and leverage them in the design and analysis of longevity-enhancing intervention studies.  TGen provides a very collaborative environment that includes basic scientists, computational and quantitative scientists, biomedical technology developers and clinicians, including those at TGen’s affiliated institution, the City of Hope Hospital in East Los Angeles, as well as its many other partner institutions.

There is tremendous interest in the identification of factors that affect human longevity and potential interventions that enhance human longevity. Unfortunately, human longevity is a complex, multifactorial phenotype with a number of interacting genetic and non-genetic determinants. Characterizing the factors influencing longevity will be difficult since the effect of any one factor can be obscured by the effects of others.  As a result, more sophisticated and integrated approaches are needed. This is true for both the identification and characterization of longevity-enhancing factors and testing longevity-enhancing interventions that target these factors. A research challenge will be to develop reliable techniques for mining data relevant to genetically-mediated factors (for example from genome-wide association studies focusing on longevity) to identify better longevity-enhancing intervention targets, as well as methods to test interventions that exploit those targets. In this context, the proposed activity and research will involve:

  • Modeling and the influence of genetic variants on human longevity using imputation and mediation tests

  • Developing strategies for identifying drugs and nutritional interventions that beneficially modulate longevity-associated factors

  • Designing studies to test interventions that target longevity-enhancing factors

  • Designing studies that measure factors that indicate changes consistent with a health benefit

  • Helping oversee the conduct of studies to identify and test factors that enhance longevity

  • Present findings on longevity enhancement at major conferences and in peer-reviewed publications

TGen has access to resources (such as some of the largest and fastest computing systems in the world, a large phase I clinical trial center, a CLIA lab, genomic and other omic assay-oriented labs) that can be leveraged in the proposed research. In addition, the development of the proposed strategies and methods will likely have a broad, international impact, given the amount of attention human longeveity research is receiving, so the research to be pursued will be highly visible and competitive, and as a result could propel the career of an independently-minded researcher looking to make an indelible impact on a biomedical science and humanity in general.

Requirements

Job Requirements                                                      

  • Ph.D. (completed or near completion) in Bioinformatics, Systems Biology, Computational or Quantitative Biology, Biostatistics, Statistics, Applied Mathematics, or a related field.

  • Computer programming, R and other statistical analysis packages, and scripting languages skills

  • Experience in developing linear and non-linear statistical models

  • An understanding of genetics and genomics

  • Experience with large biological data sets

  • Excellent written and verbal communication skills

  • Willingness to work in collaborative settings

  • No publication record is required, although a publication track record is preferred

How to Apply

If you are interested in seeing the most up to date job listings or to apply for this position, please go to https://www.tgen.org/careers-tgen/and submit your resume. Please take a moment to read about our employee benefits and learn more about TGen. If you have any questions about the company or how to apply for a position, please contact hr@tgen.org.

Only resumes submitted through the TGen career website will be considered.

We value and support diversity in our workforce.

EEO/AA

About Our Organization

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. TGen is allied with City of Hope, a world-renowned independent research and cancer and diabetes treatment center. This precision medicine alliance enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. For more information, visit: www.tgen.org.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.